• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    OptimizeRx Corporation - Common Stock (NQ:OPRX)

    8.360 +0.550 (+7.04%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 29, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 211,182
    Open 7.920
    Bid (Size) 8.120 (300)
    Ask (Size) 8.470 (100)
    Prev. Close 7.810
    Today's Range 7.821 - 8.370
    52wk Range 4.540 - 22.25
    Shares Outstanding 17,618,607
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    OptimizeRx Brings Net New Authenticated HCP Reach to The Trade Desk Through OpenPath
    Expands programmatic access to 800,000 verified prescribers directly in the EHR workflow, making OptimizeRx’s point of care inventory directly available to advertisers using The Trade Desk 
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Expands Natural Language Audience Builder to Unify HCP and DTC Audience Intelligence
    New functionality helps DSPs and agency planners create deterministic HCP and consumer audiences faster, using one single workflow 
    From OptimizeRx Corporation
    Via GlobeNewswire

    Performance

    YTD
    -32.7%
    -32.7%
    1 Month
    +4.8%
    +4.8%
    3 Month
    +54.0%
    +54.0%
    6 Month
    +29.4%
    +29.4%
    1 Year
    -59.2%
    -59.2%

    More News

    Read More
    News headline image
    OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference
    From OptimizeRx Corporation
    Via GlobeNewswire
    OptimizeRx Corp (NASDAQ:OPRX) Beats Q1 Estimates But Slashes 2026 Revenue Guidance ↗
    Via Chartmill
    OptimizeRx Corp (NASDAQ:OPRX) Beats Q4 Earnings Estimates but Offers Cautious 2026 Outlook ↗
    Via Chartmill
    News headline image
    OptimizeRx Appoints Pharma Commercialization and AI Expert Troy Sarich as Company Advisor
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx (OPRX) Q2 2026 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Artificial Intelligence Earnings
    News headline image
    OptimizeRx Q2 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms
    From OptimizeRx Corporation
    Via GlobeNewswire
    MissionIRNewsBreaks – OptimizeRx Corp. (NASDAQ: OPRX) Secures $35 Million Senior Credit Facility
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    OptimizeRx to Participate in Upcoming Investor Conferences
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    DeepIntent Becomes First Healthcare DSP to Integrate OptimizeRx’s Authenticated EHR Network
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx (OPRX) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    OptimizeRx Q1 Earnings Call Highlights ↗
    Via MarketBeat
    Topics Earnings
    News headline image
    OptimizeRx Reports First Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Launches Programmatic Access to Authenticated EHR Advertising at Scale
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Releases 2026 Environmental, Social, and Governance (ESG) Report
    From OptimizeRx Corporation
    Via GlobeNewswire
    News headline image
    OptimizeRx Sets First Quarter 2026 Conference Call for May 12, 2026, at 4:30 p.m. ET
    From OptimizeRx Corporation
    Via GlobeNewswire
    Discover the top movers in Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    OptimizeRx (OPRX) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings

    Frequently Asked Questions

    Is OptimizeRx Corporation - Common Stock publicly traded?
    Yes, OptimizeRx Corporation - Common Stock is publicly traded.
    What exchange does OptimizeRx Corporation - Common Stock trade on?
    OptimizeRx Corporation - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for OptimizeRx Corporation - Common Stock?
    The ticker symbol for OptimizeRx Corporation - Common Stock is OPRX on the Nasdaq Stock Market
    What is the current price of OptimizeRx Corporation - Common Stock?
    The current price of OptimizeRx Corporation - Common Stock is 8.360
    When was OptimizeRx Corporation - Common Stock last traded?
    The last trade of OptimizeRx Corporation - Common Stock was at 09/29/26 04:00 PM ET
    What is the market capitalization of OptimizeRx Corporation - Common Stock?
    The market capitalization of OptimizeRx Corporation - Common Stock is 147.29M
    How many shares of OptimizeRx Corporation - Common Stock are outstanding?
    OptimizeRx Corporation - Common Stock has 147M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.